AzTrials
AzTrials

Spinal StenosisPTvsSDNCT04552145

Physical Therapy vs Surgical Decompression for Lumbar Spinal Stenosis

A study testing surgery and Physiotherapy in people with Spinal Stenosis, run by Norwegian University of Science and Technology at 3 sites in Norway.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a randomized controlled multicenter trail comparing physical therapy to surgical decompression in patients with lumbar spinal stenosis. The 0-hypothesis is that there is no difference in the efficacy of structured physical therapy compared to surgical decompression. Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Spinal Stenosis
What is being tested?
surgery and Physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
232 participants
Where
3 sitesNorway
Study dates
1 Sep 2020to 31 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients describing intermittent neurogenic claudication when walking and symptoms revealed by flexion of the spine.
  • MRI shows lumbar spinal stenosis in one or two levels measured.
  • The duration of the symptoms is longer than six months
  • The patient is a candidate for surgical treatment
  • The patient is capable of physical exercise

Who cannot join

  • Vascular intermittent claudication
  • Lumbar spinal stenosis in more than two levels
  • Previous low back surgery
  • Symptomatic lumbar disc herniation
  • Degenerative scoliosis with Cobbs angle 30 degrees or more
  • Degenerative spondylolisthesis grade 2 or more
Show all 13Show fewer
  • Spondylolysis with spondylolisthesis
  • Recent osteoporotic fractures in the spine (last 6 month)
  • Severe symptomatic arthrosis in hip or knee
  • Locally advanced or metastatic cancer
  • ASA >3
  • Polyneuropathy recognized by neurography
  • Insufficient Norwegian language skills

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Greger Lønne, md phd contact

+4797114107

gloenne@me.com

Norway3 sites, 3 recruiting
  • Innlandet Hospital Trust

    Lillehammer

    Greger Lønne, md phd, gloenne@me.com

    Recruiting
  • Martina Hansen's Hospital

    Oslo

    Elisabeth Thornes, md

    Nikolaos Ikonomo, md

    Recruiting
  • St Olavs Hospital

    Trondheim

    Sasha Gulati, md phd

    Hege Andresen

    Recruiting

Other trials in Norway

About this study

Official title: Physical Therapy Versus Surgical Decompression for Lumbar Spinal Stenosis: A Multicenter Randomized Controlled Trial

This is a randomized controlled multicenter trail comparing physical therapy to surgical decompression in patients with lumbar spinal stenosis. The 0-hypothesis is that there is no difference in the efficacy of structured physical therapy compared to surgical decompression.

Our aim is to evaluate if physical therapy can serve as a nonsurgical alternative for patients with LSS, where the severity of symptoms indicates the need of surgical decompression.

Conditions
Spinal Stenosis
Being tested
surgery, Physiotherapy
Keywords
Surgery, Physical Therapy Modalities
Medical subject headings
Spinal Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • surgeryProcedure or surgery

    standard decompression surgery

  • PhysiotherapyBehavioural

    3 month physical therapy treatment including home activity based on a well defined program and 4 to 6 visits at physical therapy intervention center.

Study groups in NCT04552145
Study groupRoleWhat they receive
surgeryActive comparatorDecompression surgery
Receives: Procedure: surgery
physiotherapyActive comparatorPhysical therapy program
Receives: Behavioral: Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The proportion (%) of patients who improve 30% or more relative to baseline in Oswestry Disability Index 2.1 (ODI)

    Oswestry Disability Index 2.0 (ODI) is the most commonly used condition-specific outcome measure for spinal disorders in general. The score ranges from 0 to 100, with a lower score indicating less severe pain and disability. It has been validated into Norwegian and tested for psychometric properties.

    Measured: 6 months after index treatment

Secondary outcomes (15)
  1. Patient reported leg pain by Numeric Rating Scale (NRS)

    NRS, scores 0-10, where a higher score indicates more pain

    Measured: Baseline and 6 months

  2. Patient reported leg pain by Numeric Rating Scale (NRS)

    NRS, scores 0-10, where a higher score indicates more pain

    Measured: Baseline and 1 year

  3. Patient reported leg pain by Numeric Rating Scale (NRS)

    NRS, scores 0-10, where a higher score indicates more pain

    Measured: Baseline and 2 years

  4. Patient reported back pain by Numeric Rating Scale (NRS)

    NRS, scores 0-10, where a higher score indicates more pain

    Measured: Baseline and 6 months

  5. Patient reported back pain by Numeric Rating Scale (NRS)

    NRS, scores 0-10, where a higher score indicates more pain

    Measured: Baseline and 1 year

  6. Patient reported back pain by Numeric Rating Scale (NRS)

    NRS, scores 0-10, where a higher score indicates more pain

    Measured: Baseline and 2 years

  7. Walking capacity measured by six-minutes walk-test

    Number of patients improving by 50 m or more after six-minutes walk-test

    Measured: Baseline and 6 months

  8. Improvement in health-related quality of life

    Measured by EuroQol 5-dimensional 5-level questionnaire (EQ-5D-5L) utility index

    Measured: Baseline and 1 year, and 2 years after index treatment

  9. Improvement in health-related quality of life

    Measured by EuroQol 5-dimensional 5-level questionnaire (EQ-5D-5L) utility index

    Measured: Baseline and 2 years

  10. Fraction of patients crossing over from physical therapy to surgical decompression

    We will give the possibility to cross over to surgery 6 months, 1 year, and 2 years after index treatment

    Measured: 6 months

  11. Fraction of patients crossing over from physical therapy to surgical decompression

    We will give the possibility to cross over to surgery 6 months, 1 year, and 2 years after index treatment

    Measured: 1 year

  12. Improvement of walking and standing capacity measured with accelerometer

    We will use a body-worn tri-axial lightweight accelerometer (AX3 sensor from Axivity, York, UK) attached by a waterproof tape to the midpoint of the patients' anterior right thigh and at the lower back.

    Daily physical activity such as walking, running, standing, sitting, lying down and cycling will be monitored. By comparing the continuous activity for one week before treatment, for one week at six-, and 12-month follow-up, we will be able to objectively report about changes in the activity level (25). Since LSS-patients have symptoms while walking and standing, we will report the activity as ratios of walking/standing compare to other activity, as well as summon the three longest walking/standing periods before and after treatment.

    Measured: Baseline and 6 months

  13. Improvement of walking and standing capacity measured with accelerometer

    We will use a body-worn tri-axial lightweight accelerometer (AX3 sensor from Axivity, York, UK) attached by a waterproof tape to the midpoint of the patients' anterior right thigh and at the lower back.

    Daily physical activity such as walking, running, standing, sitting, lying down and cycling will be monitored. By comparing the continuous activity for one week before treatment, for one week at six-, and 12-month follow-up, we will be able to objectively report about changes in the activity level (25). Since LSS-patients have symptoms while walking and standing, we will report the activity as ratios of walking/standing compare to other activity, as well as summon the three longest walking/standing periods before and after treatment.

    Measured: Baseline and 1 year

  14. The proportion (%) of patients who improve 30% or more relative to baseline in Oswestry Disability Index 2.1 (ODI)

    The ODI score ranges from 0 to 100, with a lower score indicating less severe pain and disability.

    Measured: 1 year after index treatment

  15. The proportion (%) of patients who improve 30% or more relative to baseline in Oswestry Disability Index 2.1 (ODI)

    The ODI score ranges from 0 to 100, with a lower score indicating less severe pain and disability.

    Measured: 2 years after index treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2020
  2. Study start1 Sep 2020
  3. Primary completion30 Aug 2026 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomised controlled multicenter study
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
232 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04552145
Sponsor's protocol ID
2019/283
Acronym
PTvsSD
Status last verified
Jun 2025
First submitted
10 Sep 2020
Last updated
22 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing surgery and Physiotherapy in people with Spinal Stenosis, run by Norwegian University of Science and Technology at 3 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Greger Lønne, md phd (+4797114107, gloenne@me.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The proportion (%) of patients who improve 30% or more relative to baseline in Oswestry Disability Index 2.1 (ODI) (time frame: 6 months after index treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in